Altimmune, Inc. (ALT) Tops Q1 EPS by 6c

Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.18), $0.06 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22